Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page; the previous tag was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a related topic entry for generalized pustular psoriasis and a link to Genetic and Rare Diseases Information Center resources for this condition.SummaryDifference0.2%

- Check33 days agoChange DetectedAdded a new site revision tag 'Revision: v3.4.2' and removal/update of prior system notices (including a government funding/operating status notice and 'Revision: v3.4.1'). These are administrative updates and do not modify study content or its presentation.SummaryDifference0.4%

- Check40 days agoChange DetectedAdded a clinical study report synopsis, sponsor information (AbbVie), Helpful Links, and a site revision note (Revision: v3.4.1). Removed the previous revision (Revision: v3.4.0) and included a government funding notice for currency of information.SummaryDifference0.6%

- Check47 days agoChange DetectedAdded a glossary toggle and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check61 days agoChange DetectedMinor update: the page revision changed from v3.3.3 to v3.3.4; no other content or functionality appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.